Browsing: Covid-19

Medical Channel Asia presents the weekly Asian medical news bulletin, bringing you essential healthcare news from across the region. This…

The new coronavirus Omicron subvariant EG.5.1, detected in Thailand, Singapore, and Indonesia, has prompted vigilance but not panic across Asian health communities. 

A recent emergence of the EG.5 Omicron subvariant has sparked global attention. We delve into its characteristics and potential implications.

Medical Channel Asia presents the weekly Asian medical news bulletin, bringing you essential healthcare news from across the region. This…

In an unprecedented move, Moderna, a biotech firm based in Massachusetts, USA, has struck a landmark deal with Chinese officials to research, develop and manufacture messenger RNA (mRNA) medicines in China. 

Medical Channel Asia presents the weekly Asian Medical news bulletin, bringing you essential healthcare news from across the region. This week’s bulletin will focus on COVID-19 booster shots, exercise and vaping.

In a bold and strategic shift in managing COVID-19, Indonesia’s Health Ministry has announced a sweeping reform in its approach to vaccinations. This move was triggered by the pressing need to expedite the nation’s inoculation efforts against the coronavirus. By scrapping the rigid set of rules that previously dictated specific vaccine brands for different stages of immunisation, the ministry is now granting its citizens the option to receive any generally approved vaccine for their primary and booster doses.

Medical Channel Asia presents the weekly Asian medical news bulletin, bringing you essential healthcare news from across the region. This week’s bulletin will focus on Covid-19 cases and other health conditions.

Scientists from the University of Colorado (CU) Boulder have crafted an innovative breathalyser test powered by artificial intelligence (AI) that can detect COVID-19 swiftly and accurately. 

A new mRNA COVID-19 vaccine, ChulaCov19, developed in Thailand, has shown promise in Phase I trials for its durability and ability to be stored at fridge temperatures for up to three months. The development of a potentially more effective and locally-grown vaccine could have significant implications for vaccine distribution in low- and middle-income countries in the region, where storage and transport can be challenging.